Sorry, you need to enable JavaScript to visit this website.

Competitive Grants Program

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts Details
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Advancing Genomic Competence and Patient Centered Care in Metastatic Breast Cancer
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology Canada, China, France, Germany, India, Italy, Japan, Spain, United Kingdom
    Improving the Vaccination Environment to Prevent Respiratory Infectious Diseases in Older Adults and High-Risk Individuals
    Release Date:
    Review Process: Pfizer Internal
    Translation: Japanese (link)
    Quality Improvement Vaccines Japan
    Improving Shared Decision Making in Hemophilia: Visiting Professorship Program - 2026, Semester 2
    Release Date:
    Partner: Hemostasis & Thrombosis Research Society (HTRS)
    Review Process: Expert Review Panel
    Education Rare Disease USA
    Development of Healthcare Professionals with Advanced Expertise in Preventive Strategies in Pediatric Infectious Diseases
    Release Date:
    Review Process: Pfizer Internal
    Translation: Japanese (link)
    Education Vaccines Japan
    Current and Emerging Therapies: The future of Recurrent or Metastatic (r/m) Cervical Cancer
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    The Role of RSV in Functional Decline and Healthcare Dependency in Hospitalized Adults
    Release Date:
    Review Process: Expert Review Panel
    Research Vaccines Italy
    Improving the Quality and Standardization of Pneumococcal Diagnostic Pathways in Pediatric and Adult Populations
    Release Date:
    Review Process: Expert Review Panel
    Research Vaccines Italy
    Interventional Research Studies of Brentuximab Vedotin-Based Novel Combinations in AITL and PTCL-NOS
    Release Date:
    Review Process: Pfizer Internal
    Research Oncology USA
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Quality Improvement initiatives optimizing AF and VTE management in Canada
    Release Date:
    Review Process:
    Improving the Management of Patients with Uncontrolled Acromegaly (International Developed Markets)
    Release Date:
    Review Process:
    Pfizer and the National Kidney Foundation: Improving Immunization Rates of Patients with Chronic Kidney Disease Including Dialys
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital Albania
    Integrated Approach to Breast Health Equity
    Release Date:
    Review Process:
    Patient Registries In Metastatic Breast Cancer
    Release Date:
    Review Process:
    Improving Patient Care in Tobacco Dependency
    Release Date:
    Review Process:
    Antimicrobial Stewardship in the Latin America Region
    Release Date:
    Review Process:
    Management of Atopic Dermatitis – International Developed Markets
    Release Date:
    Review Process:
    Improving Standard of Care for Chronic AD
    Release Date:
    Review Process:
    NCCN and Pfizer: Enhancing Academic-Community-Patient Partnerships in Metastatic Breast Cancer Care
    Release Date:
    Review Process:
    Translating the Atopic Dermatitis (AD)
    Release Date:
    Review Process:
    UK Oncology Quality Improvement Grants
    Release Date:
    Review Process: